Share-based Payment Arrangement, Expense in USD of Ambrx Biopharma Cayman, Inc. from 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ambrx Biopharma Cayman, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2019 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2023 was $2,886,000.000, a 53.6% increase year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6,253,000.000, a 47.3% decline from 2021.
  • Ambrx Biopharma Cayman, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11,856,000.000, a 874% increase from 2020.
  • Ambrx Biopharma Cayman, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $1,217,000.000, a 33.5% decline from 2019.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $2,886,000 +$1,007,000 +53.6% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $1,938,000 +$288,000 +17.5% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q2 2022 $1,879,000 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $1,650,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023

Ambrx Biopharma Cayman, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $6,253,000 -$5,603,000 -47.3% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023
2021 $11,856,000 +$10,639,000 +8.7% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $1,217,000 -$614,000 -33.5% 01 Jan 2020 31 Dec 2020 20-F 26 Apr 2022
2019 $1,831,000 01 Jan 2019 31 Dec 2019 20-F 26 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.